...
【24h】

Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws

机译:颌骨中央巨细胞病变中降钙素和糖皮质激素受体的免疫表达

获取原文
获取原文并翻译 | 示例

摘要

Background This study analyzed the immunoexpression of calcitonin receptor ( CTR ) and glucocorticoid receptor ( GR ) in central giant cell lesions ( CGCL s) and verified potential associations with patient's response to clinical treatment with intralesional injection of triamcinolone. Materials and methods Fifty‐four cases of CGCL s, including 22 non‐aggressive, and 32 aggressive, were investigated by immunohistochemistry. Results Surgery was the therapeutic choice for 53.1% of the aggressive CGCL s, and 46.9% were submitted to the conservative treatment with intralesional triamcinolone injections. Among patients submitted to conservative treatment, 60% (n?=?9) showed favorable response. CTR expression was observed in 68.51%, and GR in 94.44% of the total sample. There were no differences in the expression of CTR , neither GR in mononucleated stromal cells ( MSC s) or multinucleated giant cells ( MGC s), in relation to aggressiveness, treatment performed for and the response to conservative treatment. Both markers showed a positive correlation between their expression in MSC s and MGC s in the total sample ( P? ? 0.0001). CTR expression on MSC s showed a positive correlation with MGC s in the aggressive and non‐aggressive groups ( P? ? 0.0001). Conclusions Calcitonin receptor and GR expression were diffuse and similar in non‐aggressive and aggressive cases, and it did not influence the response to clinical treatment with triamcinolone in the sample studied.
机译:背景技术该研究分析了中枢巨细胞病变(CGCL S)中降钙素受体(CTR)和糖皮质激素受体(GR)的免疫表达,并验证了患者对患者对胸腔内注射的临床治疗的反应的潜在关联。通过免疫组化研究了材料和方法,包括22例CGCL S的案例,包括22例非侵略性和32例侵略性。结果手术是53.1%的侵略性CGCL S的治疗选择,46.9%提交给保守治疗,含有内腔冠状酮胺注射。在提交保守治疗的患者中,60%(n?=?9)表现出有利的反应。在总样品的94.44%的68.51%,GR中观察到CTR表达。 Ctr表达没有差异,无论是单核素的基质细胞(MSC S)还是多核巨细胞(MGC S)都没有遗传,与侵略性,对保守治疗的反应进行侵略性,治疗。这两个标记显示它们在总样品中MSC S和MGC S中的表达之间的正相关性(P≤≤0.0001)。 MSC S上的CTR表达显示出与侵袭性和非侵袭性基团中的MGC S正相关(P?& 0.0001)。结论降钙素受体和GR表达在非侵略性和腐蚀性案例中弥漫性和相似,并且不会影响研究样本中司司甘油酮的临床治疗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号